Listar por autor "Sordo-Bahamonde, Christian"

A cytofluorimetric assay to evaluate intracellular cytokine production by NK cells

Sordo Bahamonde, Christian

; Lorenzo Herrero, Seila

; González Rodríguez, Segundo

; López Soto, Alejandro

(2019)

Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy

Sordo Bahamonde, Christian

; Lorenzo Herrero, Seila

; Granda Díaz, Rocío

; Martínez Pérez, Alejandra; Aguilar García, Candelaria

; Rodrigo Tapia, Juan Pablo

; García Pedrero, Juana María

; González Rodríguez, Segundo

(2023)

Bloodstream infections in hematopoietic stem cell transplant recipients colonized by multidrug-resistant bacteria

González Rodríguez, Ana Pilar

; Palomo Moraleda, P.; Suárez Pañeda, J.; Zanabili, Joud; González Muñiz, S.; Bras, L. R. Morais; Lorenzo Herrero, Seila

; Sordo Bahamonde, Christian

; Martínez Pérez, A.; González Huerta, Ana Julia (2022)

BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia

Sordo Bahamonde, Christian

; Lorenzo Herrero, Seila

; Martínez Pérez, Alejandra; González Rodríguez, A. P.; Ramírez Payer, Ángel; González García, E.; Aguilar García, C.; González Rodríguez, Sara

; López Soto, Alejandro

; García Torre, A.; González Rodríguez, Segundo

(2023)

BTLA/HVEM axis induces NK cell immunosuppression and poor outcome in chronic lymphocytic leukemia

Sordo Bahamonde, Christian

; Lorenzo Herrero, Seila

; González Rodríguez, Ana Pilar

; Ramírez Payer, Ángel; González-García E.; López Soto, Alejandro

; González Rodríguez, Segundo

(2021)

CD107a degranulation assay to evaluate immune cell antitumor activity

Lorenzo Herrero, Seila

; Sordo Bahamonde, Christian

; González Rodríguez, Segundo

; López Soto, Alejandro

(2019)

Checkpoint inhibition in the fight against cancer: NK cells have some to say in it

Sordo Bahamonde, Christian

; Lorenzo Herrero, Seila

; González Rodríguez, Ana Pilar

; González Rodríguez, Segundo

(2021)

Chemo-immunotherapy: a new trend in cancer treatment

Sordo Bahamonde, Christian

; Lorenzo Herrero, Seila

; González Rodriguez, A. P.; Martínez Pérez, Alejandra; Rodrigo Tapia, Juan Pablo

; García Pedrero, J. M.; González Rodríguez, Segundo

(2023)

Correction to: deciphering lag-3: unveiling molecular mechanisms and clinical advancements (biomarker research, (2024), 12, 1, (126), 10.1186/s40364-024-00671-0)

Martínez Pérez, Alejandra; Granda Díaz, Rocío

; Aguilar García, Candelaria

; Sordo Bahamonde, Christian

; González Rodríguez, Segundo

(2024)

Cystatin C-based equations detect hidden kidney disease and poor prognosis in newly diagnosed patients with multiple myeloma

Cepeda Piorno, F. J.; González García, E.; Méndez Gallego, A.; Torres Varona, J.; García Moreira, V.; Sordo Bahamonde, Christian

; Alberdigarcía del Castillo, C.; Astobieta Madariaga, E.; Mateos Manteca, M. V.; González Rodríguez, Segundo

(2022)

Deciphering lag-3: unveiling molecular mechanisms and clinical advancements

Martínez Pérez, Alejandra; Granda Díaz, Rocío

; Aguilar García, Candelaria

; Sordo Bahamonde, Christian

; González Rodríguez, Segundo

(2024)

Determinación de nuevas dianas terapéuticas en el tratamiento de la leucemia linfática crónica

Sordo Bahamonde, Christian

(2021-11-12)

Driver mutations and single copy number abnormalities identify binet stage a patients with chronic lymphocytic leukemia with aggressive progression

González Rodríguez, Ana Pilar

; Payer, Ángel R.; Menéndez Suárez, Juan J.; Sordo Bahamonde, Christian

; Lorenzo Herrero, Seila

; Zanabili, Joud; Fonseca, Ariana; González Huerta, Ana Julia; Palomo, Pilar; González Rodríguez, Segundo

(2020)

Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay

Lorenzo Herrero, Seila

; Sordo Bahamonde, Christian

; González Rodríguez, Segundo

; López Soto, Alejandro

(2020)

A flow cytometric NK cell-mediated cytotoxicity assay to evaluate anticancer immune responses In vitro

Lorenzo Herrero, Seila

; Sordo Bahamonde, Christian

; González Rodríguez, Segundo

; López Soto, Alejandro

(2019)

Hyperalgesic effect evoked by il-16 and its participation in inflammatory hypernociception in mice

González Rodríguez, Sara

; Sordo Bahamonde, Christian

; Álvarez Artime, Alejandro

; Baamonde Arbaiza, Ana Isabel

; Menéndez Antolín, Luis

(2024)

Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia

Villa Álvarez, Mónica

; Sordo Bahamonde, Christian

; Lorenzo Herrero, Seila

; González Rodríguez, Ana Pilar

; Ramírez Payer, Ángel; González García, María Esther

; Villa Álvarez, María Cristina; López Soto, Alejandro

; González Rodríguez, Segundo

(2018)

Immunoglobulin-like transcript 2 blockade restores antitumor immune responses in glioblastoma

Lorenzo Herrero, Seila

; Sordo Bahamonde, Christian

; Martínez Pérez, Alejandra; Corte Torres, María Daniela

; Fernández Vega, Iván

; Solís Hernández. M. P.; González Rodríguez, Segundo

(2023)

Involvement of CD4+ and CD8+ T-lymphocytes in the modulation of nociceptive processing evoked by CCL4 in mice

González Rodríguez, Sara

; Lorenzo Herrero, Seila

; Sordo Bahamonde, Christian

; Hidalgo Balsera, Agustín

; González Rodríguez, Segundo

; Menéndez Antolín, Luis

; Baamonde Arbaiza, Ana Isabel

(2022)

LAG‐3 blockade with Relatlimab (BMS‐986016) restores anti‐leukemic responses in chronic lymphocytic leukemia

Sordo Bahamonde, Christian

; Lorenzo Herrero, Seila

; González Rodríguez, Ana Pilar

; Ramírez Payer, Ángel; González García, Esther; López Soto, Alejandro

; González Rodríguez, Segundo

(2021)

Listar por autor "Sordo-Bahamonde, Christian"

A cytofluorimetric assay to evaluate intracellular cytokine production by NK cells ﻿

Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy ﻿

Bloodstream infections in hematopoietic stem cell transplant recipients colonized by multidrug-resistant bacteria ﻿

BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia ﻿

BTLA/HVEM axis induces NK cell immunosuppression and poor outcome in chronic lymphocytic leukemia ﻿

CD107a degranulation assay to evaluate immune cell antitumor activity ﻿

Checkpoint inhibition in the fight against cancer: NK cells have some to say in it ﻿

Chemo-immunotherapy: a new trend in cancer treatment ﻿

Correction to: deciphering lag-3: unveiling molecular mechanisms and clinical advancements (biomarker research, (2024), 12, 1, (126), 10.1186/s40364-024-00671-0) ﻿

Cystatin C-based equations detect hidden kidney disease and poor prognosis in newly diagnosed patients with multiple myeloma ﻿

Deciphering lag-3: unveiling molecular mechanisms and clinical advancements ﻿

Determinación de nuevas dianas terapéuticas en el tratamiento de la leucemia linfática crónica ﻿

Driver mutations and single copy number abnormalities identify binet stage a patients with chronic lymphocytic leukemia with aggressive progression ﻿

Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay ﻿

A flow cytometric NK cell-mediated cytotoxicity assay to evaluate anticancer immune responses In vitro ﻿

Hyperalgesic effect evoked by il-16 and its participation in inflammatory hypernociception in mice ﻿

Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia ﻿

Immunoglobulin-like transcript 2 blockade restores antitumor immune responses in glioblastoma ﻿

Involvement of CD4+ and CD8+ T-lymphocytes in the modulation of nociceptive processing evoked by CCL4 in mice ﻿

LAG‐3 blockade with Relatlimab (BMS‐986016) restores anti‐leukemic responses in chronic lymphocytic leukemia ﻿

A cytofluorimetric assay to evaluate intracellular cytokine production by NK cells

Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy

Bloodstream infections in hematopoietic stem cell transplant recipients colonized by multidrug-resistant bacteria

BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia

BTLA/HVEM axis induces NK cell immunosuppression and poor outcome in chronic lymphocytic leukemia

CD107a degranulation assay to evaluate immune cell antitumor activity

Checkpoint inhibition in the fight against cancer: NK cells have some to say in it

Chemo-immunotherapy: a new trend in cancer treatment

Correction to: deciphering lag-3: unveiling molecular mechanisms and clinical advancements (biomarker research, (2024), 12, 1, (126), 10.1186/s40364-024-00671-0)

Cystatin C-based equations detect hidden kidney disease and poor prognosis in newly diagnosed patients with multiple myeloma

Deciphering lag-3: unveiling molecular mechanisms and clinical advancements

Determinación de nuevas dianas terapéuticas en el tratamiento de la leucemia linfática crónica

Driver mutations and single copy number abnormalities identify binet stage a patients with chronic lymphocytic leukemia with aggressive progression

Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay

A flow cytometric NK cell-mediated cytotoxicity assay to evaluate anticancer immune responses In vitro

Hyperalgesic effect evoked by il-16 and its participation in inflammatory hypernociception in mice

Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia

Immunoglobulin-like transcript 2 blockade restores antitumor immune responses in glioblastoma

Involvement of CD4+ and CD8+ T-lymphocytes in the modulation of nociceptive processing evoked by CCL4 in mice

LAG‐3 blockade with Relatlimab (BMS‐986016) restores anti‐leukemic responses in chronic lymphocytic leukemia